175
Participants
Start Date
March 12, 2019
Primary Completion Date
May 11, 2021
Study Completion Date
May 25, 2023
Ravulizumab
Concentrated sterile, preservative-free aqueous solution (10 milligrams \[mg\]/milliliter \[mL\]) in single-use, 30-mL vial for intravenous (IV) infusion. Single loading dose on Day 1, followed by regular maintenance dosing beginning on Day 15, based on weight.
Placebo
Matching, sterile, preservative-free aqueous solution in single-use, 30-mL vial for IV infusion. Single loading dose on Day 1, followed by regular maintenance dosing beginning on Day 15, based on weight.
Research Site, Vienna
Research Site, Copenhagen
Research Site, Nice
Research Site, Arhus C
Research Site, Zurich
Research Site, Aalborg
Research Site, New York
Research Site, Berlin
Research Site, Great Neck
Research Site, Prague
Research Site, Marseille
Research Site, Pittsburgh
Research Site, Hershey
Research Site, Philadelphia
Research Site, Washington D.C.
Research Site, Milan
Research Site, Hamburg
Research Site, Baltimore
Research Site, Richmond
Research Site, Bergamo
Research Site, Morgantown
Research Site, Chapel Hill
Research Site, Durham
Research Site, Madrid
Research Site, Charlotte
Research Site, North Charleston
Research Site, Charleston
Research Site, Murcia
Research Site, Jacksonville
Research Site, Tampa
Research Site, Bologna
Research Site, Lexington
Research Site, Daegu
Research Site, Columbus
Research Site, Cleveland
Research Site, Essen
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, Ann Arbor
Research Site, Münster
Research Site, East Lansing
Research Site, Grand Rapids
Research Site, Yangsan
Research Site, Lille
Research Site, Rolling Meadows
Research Site, Chicago
Research Site, Columbia
Research Site, Kansas City
Research Site, Dallas
Research Site, Houston
Research Site, Round Rock
Research Site, Austin
Research Site, Aurora
Research Site, Napoli
Research Site, Fort Collins
Research Site, Colorado Springs
Research Site, Phoenix
Research Site, Phoenix
Research Site, Phoenix
Research Site, Las Vegas
Research Site, Las Vegas
Research Site, Sylmar
Research Site, Loma Linda
Research Site, Garches
Research Site, Irvine
Research Site, San Francisco
Research Site, Palo Alto
Research Site, Würzburg
Research Site, Haifa
Research Site, Tel Aviv
Research Site, Fairfield
Research Site, Boston
Research Site, Burlington
Research Site, Burlington
Research Site, Edmonton
Research Site, London
Research Site, Toronto
Research Site, Montreal
Research Site, Brno
Research Site, Ostrava
Research Site, Leipzig
Research Site, Roma
Research Site, Rome
Research Site, Bunkyō City
Research Site, Chiba
Research Site, Fukuoka
Research Site, Hanamaki-shi
Research Site, Kawagoe-shi
Research Site, Moriguchi-shi
Research Site, Nagoya
Research Site, Niigata
Research Site, Osaka
Research Site, Sapporo
Research Site, Sapporo
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Ube-shi
Research Site, Amsterdam
Research Site, Leiden
Research Site, Porto
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY